The British Heart Foundation (BHF) announced that it will invest £30 million in CureHeart to develop a cure for genetic cardiomyopathies.

During the second challenging year of the pandemic, EHN together with its members, took the initiative to bring cardiovascular health higher on the European policy agenda.

EHN welcomes the European Commission's latest proposal to prohibit the sale of flavoured heated tobacco products (HTPs) in the EU.

Dr Charmaine Griffiths, Chief Executive Officer of the British Heart Foundation, has been announced as President of the European Heart Network.

On World Obesity day, EHN calls on decision makers to protect children from the marketing of nutritionally poor food. It is time for an effective regulatory framework.

The European Union (EU) must adopt legislation to effectively protect children from the harmful impacts of the widespread, ubiquitous and insidious marketing of nutritionally poor food.

Heated Tobacco Products are particularly harmful to the cardiovascular system as they increase the heart rate and blood pressure (similar to conventional cigarettes).  HTPs have similar devastating effects on cardiovascular health as conventional cigarettes.

Do you live with an Implantable Cardioverter-Defibrillator (ICD)?

Share your experience in this survey and help physicians understand your needs to tailor future information and counselling.

As of today, 1 April 2021, foods containing more than 2g/100g of industrially produced trans fatty acids are no longer allowed on the EU market. The removal of these trans fatty acids (TFAs) from the food supply is one of the most straightforward public health interventions in the EU.

To reduce the onset of cardiovascular disease, it is crucial to identify those persons at high risk of developing CVD, and to provide them with appropriate advice and preventive treatment.